Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors

The expression of human epidermal growth factor receptor 2 (HER2) protein or gene transcripts is critical for therapeutic decision making in breast cancer. We examined the performance of a digitalized and artificial intelligence (AI)-assisted workflow for HER2 status determination in accordance with...

Descripción completa

Detalles Bibliográficos
Autores principales: Palm, Christiane, Connolly, Catherine E., Masser, Regina, Padberg Sgier, Barbara, Karamitopoulou, Eva, Simon, Quentin, Bode, Beata, Tinguely, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818571/
https://www.ncbi.nlm.nih.gov/pubmed/36611460
http://dx.doi.org/10.3390/diagnostics13010168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818571/
https://www.ncbi.nlm.nih.gov/pubmed/36611460
http://dx.doi.org/10.3390/diagnostics13010168

Ejemplares similares